Abstract
Introduction

42
Drug-resistant tuberculosis (DR-TB) threatens global TB prevention and control.
43
MDR-TB, defined as TB resistant to at least rifampin (RFP) and isoniazid (INH), has 44 longer treatment regimens and lower treatment success rate with supplies of less 45 effective and more toxic second-line drugs [1] . RR-TB, defined as TB resistant to at 46 least RFP, also requires a second-line regimen, and 83% of RR-TB cases have 100,000 population which was 27.5% higher than the rate of the whole country. In 
77
Methods
78
Study design and data collection
79
This was an observational retrospective study of notified MDR/RR-TB cases non-farmers. The regional disparity of TB notification has also been evaluated.
91
According to the division of local government, there were four regions in Chongqing 
Statistical analysis
196
The chi-square test for linear trend was used to test the trend of the notification (Fig 1) . The XDR-TB cases per 100,000 population (χ 2 trend=264.69, P=1.63×10 -59 ) (Fig 2) . 
Regional disparity of MDR/RR-TB notification
242
The MDR/RR-TB notification rate was significantly different in four regions 243 (χ 2 =2102.04, P<0.05), and the MDR/RR-TB notification rate of Urban Districts has 244 been higher than other three regions since 2014 (Fig 3) MDR/RR-TB notification rate was less than 1 case per 100,000 population. (Fig 4) . treatment failure rate and rate of loss to follow-up were 13.49%, 9.21%, and 13.82% 
P=0.001).
283
From 2016 to 2017, the drug resistance rate for RFP has declined significantly 284 from 16.42% to 5.69% in new TB cases (χ 2 trend=77.24, P=1.52× 10 -18 ) (Fig 6) . In 285 2016 and 2017, the drug resistance rate for RFP was 38.13% and 37.62% respectively 286 in previously treated TB cases, which didn't change significantly (χ 2 trend=0.08, (Fig 7) .
287
P=0.78)
288
In 2011, some drug resistance rates had a peak in previously treated TB cases, 14 289 which were higher than the rates in 2010 and 2012 (Fig 7) . 
Risk factors associated with MDR/RR-TB
303
The risk factors associated with MDR/RR-TB were analyzed ( 
Discussion
319
The MDR/RR-TB notification rate has increased significantly since 2010 in 320
Chongqing. There were several reasons for this increase of MDR/RR-TB notification should be further strengthened with more investment by government.
347
In Chongqing, the MDR/RR-TB notification rate of male was significantly 348 higher than the rate of female, and male was more likely to develop MDR/RR-TB 
358
The MDR/RR-TB notification rate of over-60-year age group was not the highest
359
in the four age groups. But our correlation analysis based on screening data showed 360 that only over-60-year age group was the risk factor associated with MDR/RR-TB.
361
There may be a contradiction between the two sets. This contradiction may indicate 362 that the MDR/RR-TB notification in over-60-year age group was under-reported.
363
Other study also showed that aging was a risk factor of MDR/RR-TB 
420
In conclusion, MDR/RR-TB control over the years has been effective in
421
Chongqing, and more and more MDR/RR-TB cases have been notified and treated.
422
But the prevalence of MDR/RR-TB is still high, and facing the challenges including 423 detection and treatment gaps, the regional disparity due to socioeconomic status, the 424 under-notification in elderly people, and the high notification rate in farmers.
425
Sustained government financing and policy support should be guaranteed to ensure 426 universal access to effective MDR/RR-TB medical care. 
